EACR 2026 Congress: Innovative Cancer Science

Quanterix is excited to connect with researchers to advance cancer research.

Quanterix is proud to participate in EACR 2026 from June 8-11, 2026 in Budapest, Hungary. The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. 

Advancing cancer research through ultrahigh-plex spatial proteomics

At EACR 2026, Quanterix—together with Akoya Biosciences, now part of Quanterix—will engage with researchers focused on unraveling the cellular, molecular, and spatial dynamics that drive cancer progression, metastasis, and therapeutic response. This long-standing conference will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. We are eager to highlight our spatial biology platforms that enable researchers to move seamlessly from ultrahigh-plex biomarker detection to high‑throughput spatial signatures, delivering deep insights into cancer biology.

Join us for our poster presentations

Presenter: Kai Bouché, PhD | Regional Sales Director, EMEA South & Distribution, Quanterix
Title: Spatial immunometabolic profiling of non-small cell lung cancer reveals distinct immune exclusion patterns and functional niches
Poster Session: 09 June 2026 from 10:30 to 20:00

Presenter: Dusan Zencak, PhD, Sr Business Development and Distribution Manager, Quanterix
Title: Cellular decomposition and metabolic profiling of the tumour microenvironment tumour-stroma interface using high-dimensional spatial proteomics and image analytics
Poster Session: 09 June 2026 from 10:30 to 20:00

Why connect with Quanterix?

Conference attendees are invited to connect with us at booth #47 to explore how spatial biology solutions help researchers understand cancer in situ. Our spatial technologies reveal how cells, phenotypes, and pathways interact within complex tumor ecosystems.

Our spatial platforms support research in:

• Tumor heterogeneity and metastatic biology, enabling visualization of distinct cell populations and functional states within intact tissue.
• Immune‑oncology and the tumor microenvironment, mapping immune–tumor interactions that influence progression and therapeutic response.
• Translational cancer research, linking spatial tissue insights with biomarker studies across discovery and development.
• Integrated study strategies, combining spatial tissue data with quantitative protein analysis from blood.

By placing molecular data into spatial context, Quanterix helps researchers generate clear, actionable insights into cancer biology.